General MedicationsINJECTIONStandard
CEFAZOLIN SODIUM
CEFAZOLIN SODIUM
Standard Dose
EQ 10GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CEFAZOLIN SODIUM is listed in Drugs@FDA under application 209217 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2018-10-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFAZOLIN SODIUM is listed in Drugs@FDA under application 209217 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CEFAZOLIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 10GM BASE/VIAL Sponsor QILU ANTIBIOTICS Submission history Latest submission status date: 2018-10-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.